Morgan Stanley analyst Stephen Byrd maintains First Solar (NASDAQ:FSLR) with a Equal-Weight and raises the price target from $136 to $146.
Morgan Stanley Initiates Coverage On Ventyx Biosciences with Overweight Rating, Announces Price Target of $45
Morgan Stanley analyst Simon Flannery initiates coverage on Ventyx Biosciences (NASDAQ:VTYX) with a Overweight rating and announces Price Target of $45.